Oligomerix Employee Directory

Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer's disease. The company's drug discovery platform has identified a pipe... line of novel small molecule inhibitors, with preclinical IND-enabling studies nearing completion for the lead program. Oligomerix's small molecule approach blocks the formation of all tau aggregates by targeting tau self-association, the first step of the tau aggregation cascade, whereas other companies have focused on targeting large tau aggregates formed downstream. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine. Follow Oligomerix on Twitter and LinkedIn. Oligomerix is seeking strategic partners to support the acceleration and advancement of these important programs.Read More